Combinations for diabetes
Patent 6011049 Issued on January 4, 2000. Estimated Expiration Date: 
November 9, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
November 9, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorApplicationNo. 189132 filed on 11/09/1998US Classes:514/369, Chalcogen bonded directly to ring carbon of the thiazole ring514/342, Ring sulfur in the additional hetero ring514/593, Sulfur is part of a substituent which contains additional nitrogen514/635, Biguanides (i.e., N=C(-N)-N(N-)C=N)514/866DIABETESExaminersPrimary: Jordan, KimberlyAttorney, Agent or FirmForeign Patent References
International ClassesA61K 031/44A61K 031/425 A61K 031/175 A61K 031/155 AbstractCombinations of a glitazone antidiabetic agent and a biguanide antidiabetic agent, and optionally a sulfonylurea antidiabetic agent, are useful for treating diabetes mellitus and improving glycemic control.Other References
| |
